Immune Checkpoint Inhibitor Metastatic NSCLC: Combination Strategies - Episode 1

Common Adverse Events to Immunotherapies in mNSCLC

A lung cancer expert describes the common adverse events he sees with immunotherapy in mNSCLC, and the available management strategies.